Therapy Areas: Diabetes
Sinclair Research, Turner Scientific Partner to Offer GLP Ototoxicity Testing Services
11 March 2019 - - US-based nonclinical services provider Sinclair Research and US-based nonclinical hearing research specialist Turner Scientific have formed an exclusive partnership to offer GLP auditory testing to evaluate efficacy and detect and define potential ototoxicity of compounds and devices progressing toward IND/IDE approval and clinical trials, the companies said.

Sinclair Research Center, a preclinical contract research organisation, offers animal efficacy models, IND-enabling and specialty toxicology services and compliant research capabilities to support biopharmaceutical, animal health and medical device development programmes.

Sinclair is experienced in all research models and the undisputed experts in miniature swine.

With more than 50 years' experience, Sinclair has emerged as a leader in diabetes, dermal, otic and animal health research services with streamlined quality systems supporting both VICH and GLP compliant studies and SEND reporting with no backlog.

Turner Scientific is a preclinical contract research organisation specialising in hearing research, provides non-GLP and GLP research services to advance sponsor compounds and devices toward IND/IDE approval and clinical trials.

The company serves a range of biotechnology companies and pharmaceutical sponsors by evaluating therapeutic efficacy of new compounds, and by assessing the potential for ototoxicity, hearing loss, development of tinnitus, and balance/vestibular disorders.

Turner Scientific provides niche expertise, unmatched study design and execution, data analysis, specialty report writing, and sponsor communication by hearing research experts.
Login
Username:

Password: